181 related articles for article (PubMed ID: 23307189)
41. Nephrogenic adenoma: clinical features and therapeutic considerations.
Berger BW; Bhagavan SB; Reiner W; Engel R; Lepor H
J Urol; 1981 Dec; 126(6):824-6. PubMed ID: 6798226
[TBL] [Abstract][Full Text] [Related]
42. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
[TBL] [Abstract][Full Text] [Related]
43. [A case of clear cell adenocarcinoma of the female urethra].
Yamaguchi Y; Miyagawa Y; Tsujimura A; Nonomura N; Matsumiya K; Okuyama A; Koyama M; Tsujimoto Y; Aozasa K; Hanafusa T; Miura H
Hinyokika Kiyo; 2003 Oct; 49(10):627-30. PubMed ID: 14655611
[TBL] [Abstract][Full Text] [Related]
44. Cytologic features of clear cell carcinoma of the urethra and urinary bladder.
Doria MI; Saint Martin G; Wang HH; Blumstein A; Jensen JA; Maslan AM; Gattuso P
Diagn Cytopathol; 1996 Mar; 14(2):150-4. PubMed ID: 8964172
[TBL] [Abstract][Full Text] [Related]
45. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features.
Mantoan Padilha M; Billis A; Allende D; Zhou M; Magi-Galluzzi C
Histopathology; 2013 May; 62(6):941-53. PubMed ID: 23551615
[TBL] [Abstract][Full Text] [Related]
46. Nephrogenic adenoma of the urinary tract: a review.
Alexiev BA; LeVea CM
Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
[TBL] [Abstract][Full Text] [Related]
48. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.
Aydin H; Young RH; Ronnett BM; Epstein JI
Am J Surg Pathol; 2005 Apr; 29(4):520-3. PubMed ID: 15767808
[TBL] [Abstract][Full Text] [Related]
49. Primary clear cell adenocarcinoma of female urinary tract: a case report and literature review.
Miao J; Hu J; Wu J; Guo W; Chen J; Li J
BMC Womens Health; 2022 Jun; 22(1):251. PubMed ID: 35751118
[TBL] [Abstract][Full Text] [Related]
50. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
Cox R; Vang R; Epstein JI
Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
[TBL] [Abstract][Full Text] [Related]
51. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
52. GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall.
Akgul M; Humble R; Osme A; Yuce S; Kocak EN; Najafzadeh P; Sangoi A; Pattnaik N; Mishra S; Sharma S; Shaker N; Kaushal S; Baisakh M; Lightle AR; Balzer BL; Xiao GQ; MacLennan GT; Osunkoya AO; Parwani A; Cheng L; Bellizzi A; Mohanty SK
Diagn Pathol; 2022 Nov; 17(1):87. PubMed ID: 36320040
[TBL] [Abstract][Full Text] [Related]
53. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
Tregnago AC; Epstein JI
Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
[TBL] [Abstract][Full Text] [Related]
54. Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis.
Harari SE; Cheng L; Osunkoya AO
Hum Pathol; 2016 Jan; 47(1):132-7. PubMed ID: 26552875
[TBL] [Abstract][Full Text] [Related]
55. Tubular adenoma of the urinary tract: a newly described entity.
Kao CS; Epstein JI
Hum Pathol; 2013 Sep; 44(9):1890-4. PubMed ID: 23664485
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
57. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
[TBL] [Abstract][Full Text] [Related]
58. Clear cell adenocarcinoma of the urethra: review of the literature.
Venyo AK
Int J Surg Oncol; 2015; 2015():790235. PubMed ID: 25685552
[TBL] [Abstract][Full Text] [Related]
59. Primary adenocarcinoma of the female urethra with three histologic patterns and partial AFP positivity.
Hanai J; Lin M
Acta Pathol Jpn; 1990 Nov; 40(11):838-44. PubMed ID: 1706555
[TBL] [Abstract][Full Text] [Related]
60. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra.
Paner GP; Lopez-Beltran A; Amin MB
Am J Surg Pathol; 2021 Apr; 45(4):543-549. PubMed ID: 33284194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
